Novo Nordisk expands research collaboration in novel delivery technologies for biologic medicines | Science|Business
Novo Nordisk builds R&D capacity in cardiovascular and liver diseases | Science | AAAS
Who we Are | Novo Nordisk U.S.
Henning Larsen | Novo Nordisk Global Head Office
Novo Nordisk | Official Profile
Novo Nordisk, Flagship's forward-thinking partnership aims to treat cardiometabolic, rare diseases | Fierce Biotech
Novo Nordisk launches 'strong' guidance, warns of supply constraints | Reuters
Novo Nordisk Headquarters – ArcDog
Novo Nordisk - JDRF
Ozempic, Wegovy Maker Novo's Rise Forces Denmark to Keep Rates Lower: Danske - Bloomberg
Novo Nordisk investing $117.4M in manufacturing site in Denmark | Fierce Pharma
Novo Nordisk - Our Headquarters in Denmark has turned orange to mark #WorldPatientSafetyDay 🧡 Stay safe, everyone! | Facebook
Wegovy, the newest weight loss drug, comes with a high cost - Los Angeles Times
Novo Nordisk plans big API project in Denmark
Novo Nordisk to invest $2.3bn to expand manufacturing facilities
Ozempic and Wegovy, Novo Nordisk's Weight Loss Drugs, Reshape Denmark's Economy - The New York Times
The Novo Nordisk Foundation - Art Hub Copenhagen
Novo Nordiskt to invest more than 17 billion DKK in manufacturing facilities - Nordic Life Science – the leading Nordic life science news service
Novo Nordisk invests DKK 5.4 bn Danish kroner in expansion of clinical manufacturing facilities in Bagsværd, Denmark - The Danish-UK Association
Novo Nordisk Headquarters – ArcDog
Novo Nordisk announces conclusion of U.S. federal investigation of marketing practices
Novo Nordisk invests €2.1bn in Hillerød manufacturing expansion
Novo Nordisk adding in-house fill-finish capacity for Wegovy's European pen, Ozempic | Reuters
Ozempic's Surging Popularity Has Novo Nordisk (NVO) Struggling to Meet Demand - Bloomberg
